CCL Home Page
Up Directory CCL 09.06.04 Structure-Based Drug Design Conference
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Wed Sep 3 10:37:04 2008
Subject: 09.06.04 Structure-Based Drug Design Conference
CALL FOR SPEAKERS:
CHI's 9th Annual Structure-Based Drug Design
June 4-5, 2009
Royal Sonesta Hotel, Cambridge, MA  USA

Submit your speaker propsal on-line:
http://www.healthtech.com/sbd/es.aspx

2009 Program Suggestions:
For those of you not yet sure of your topic for submission, please mark 
your calendar and share some suggestions with us so we can improve next 
year’s program. Please email me key topic and speaker suggestions for 
the 2009 program at mlieberman~~pharmaseries.com

Key Topics and Speakers: What for you are the key topics and areas of 
interest upon which we should focus (top 6-8) in 2009? Why? If you 
attended in 2008, are there some issues we covered in 2008 on which
we should spend less time or some on which we should spend more time? 
Who would you like to see address the issues you mentioned?

Sincerely,
Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute
Email:  mlieberman~~pharmaseries.com
NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to ~~ to fight spam. Before you send e-mail, you need to change ~~ to @
For example: change joe~~big123comp.com to joe@big123comp.com
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.

Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!

Modified: Wed Sep 3 14:37:04 2008 GMT
Page accessed 5870 times since Wed Sep 3 14:37:05 2008 GMT

Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.